BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial

BACKGROUND: A large, double-blind, randomised, placebo-controlled trial of repeat BCG found 49% efficacy against leprosy but no protection against tuberculosis after 6–9 years’ follow-up in 1995. We report here additional follow-up, which resulted in greatly increased tuberculosis case numbers, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Glynn, Judith R, Fielding, Katherine, Mzembe, Themba, Sichali, Lifted, Banda, Louis, McLean, Estelle, Kanjala, Chifundo, Crampin, Amelia C, Ponnighaus, Jorg M, Warndorff, David K, Fine, Paul E M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459381/
https://www.ncbi.nlm.nih.gov/pubmed/34534489
http://dx.doi.org/10.1016/S2214-109X(21)00309-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459381/
https://www.ncbi.nlm.nih.gov/pubmed/34534489
http://dx.doi.org/10.1016/S2214-109X(21)00309-0

Ejemplares similares